Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Adds Clinical Genetics Execs; Deltagen Hires R&D VP

NEW YORK, June 5 - Third Wave Technologies said today that it had hired two new executives to pump up its clinical genetic testing services division.

 

The company appointed Donagh McCarthy senior vice president and general manager of the clinical business unit. McCarthy was most recently CEO of Protiveris, a private proteomics company, and general manager of Bacter's Renal division.

 

Third Wave also hired Jake Orville as sales director for the division. He was most recently national sales manager at SIMS Portex, which manufactures medical products.

 

Third Wave, based in Madison, Wis., develops, produces and markets genetic analysis products.

 


 

Gaithersburg, Md.-based Psychiatric Genomics said on June 4 that it had retained Bradley Lorimier as a director and business development consultant.

 

Lorimier was senior vice president for business development at Human Genome Sciences until 1997, when he retired.

 

Psychiatric Genomics develops treatments for mental illness by searching for gene-expression patterns associated with psychiatric disease.

 


 

Deltagen said on May 31 that Geoffrey Yarranton had joined the company as executive vice president of R&D.

 

Yarranton will guide drug discovery efforts toward clinical trials and direct the integration of the company's discovery projects.

 

Yarranton was previously senior vice president for R&D at Coulter, and became head of the South San Francisco site after the company's merger with Corixa. Before that he was in research at Celltech.

 

Deltagen also said that Peter Myers, executive vice president of subsidiary Deltagen Research Laboratories, had resigned. Deltagen acquired this division from Bristol-Myers Squibb in February 2002

 


 

Bangalore bioinformatics startup Molecular Connections has added Eitan Rubin to its scientific advisory board, the firm said on May 25.

 

Eitan, previously at Compugen, is now head of the bioinformatics and biological computing unit at the Weizmann Institute of Science in Rehovot, Israel.

 

He joins Rockefeller University plant molecular biologist Nam-Hai Chua on the board.

 

Molecular Connections was founded last August as a joint venture between a health-care incubator and the Lab for Information Technology, a Singaporean national research institute.

 


 

Geert Wenes has joined the National Center for Genome Resources as program leader for bioinformatics, the institute said on May 29.

 

Wenes, a physics and high-performance computing expert, will direct new initiatives in bioinformatics and computational biology.

 

Wenes was previously involved in IBM's Life Sciences division, where he managed the technical support center for the company's life sciences and bioinformatics units.

 

His academic training is in theoretical physics, and he did post-doc work at Los Alamos National Laboratory and at the Dutch Nuclear Physics Accelerator Institute.

 

The National Center for Genome Resources is a nonprofit institute focused on systems biology, computational biology, and bioinformatics.

 


 

Caliper Technologies said on May 22 that it had named William Kruka vice president of business development.

 

Kruka will broaden the market for Caliper's microfluidics products and systems, and promote the company's growth and development.

 

He was most recently senior manager of business development at Applied Biosystems, where he led proteomics initiatives, including mass spectrometry, chromatography and microfluidics.

 

He reports to Vice President of Corporate Development Michael Knapp, who is scheduled to become CEO on July 1, 2002.

 



Promoted? Changing jobs? GenomeWeb wants to know. E-mail Kat McGowan at
[email protected] to appear in PEOPLE, a roundup of personnel comings and goings in genomics that runs every Wednesday.
The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.